Cargando…

Epidemiology of E. coli in Cystic Fibrosis Airways Demonstrates the Capacity for Persistent Infection but Not Patient-Patient Transmission

Escherichia coli is frequently isolated from the respiratory secretions of cystic fibrosis (CF) patients yet is not considered a classical CF pathogen. Accordingly, little is known about the natural history of this organism in the CF airways, as well as the potential for patient-to-patient transmiss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izydorczyk, Conrad, Waddell, Barbara, Edwards, Brett D., Greysson-Wong, Jasper, Surette, Michael G., Somayaji, Ranjani, Rabin, Harvey R., Conly, John M., Church, Deirdre L., Parkins, Michael D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100150/ https://www.ncbi.nlm.nih.gov/pubmed/32265892 http://dx.doi.org/10.3389/fmicb.2020.00475

Ejemplares similares

Stenotrophomonas maltophilia natural history and evolution in the airways of adults with cystic fibrosis
por: Izydorczyk, Conrad, et al.
Publicado: (2023)

The natural history and genetic diversity of Haemophilus influenzae infecting the airways of adults with cystic fibrosis
por: Izydorczyk, Conrad, et al.
Publicado: (2022)

1481. Clinical Outcomes of Escherichia coli Infections in Cystic Fibrosis (CF) Patients
por: Edwards, Brett, et al.
Publicado: (2018)

Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study
por: Edwards, B D, et al.
Publicado: (2019)

Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis
por: Skolnik, Kate, et al.
Publicado: (2015)

Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
por: Acosta, Nicole, et al.
Publicado: (2020)

Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response
por: Lam, John C, et al.
Publicado: (2015)

Azithromycin and the microbiota of cystic fibrosis sputum
por: Acosta, Nicole, et al.
Publicado: (2021)

Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
por: Woo, Taylor E., et al.
Publicado: (2018)

The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
por: Heirali, Alya A., et al.
Publicado: (2017)

Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa
por: Somayaji, R., et al.
Publicado: (2015)

65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis
por: Somayaji, R., et al.
Publicado: (2015)

A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome
por: Woo, T. E., et al.
Publicado: (2019)

Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome
por: Sibley, Christopher D., et al.
Publicado: (2011)

Incidence and Outcomes of Endophthalmitis Associated Hospitalizations in Children Aged ≤ 20 Years: A Population-Based Cohort Study
por: Edwards, Brett, et al.
Publicado: (2017)

Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis
por: Whelan, Fiona J., et al.
Publicado: (2017)

Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections
por: Heirali, Alya, et al.
Publicado: (2016)

Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient
por: Workentine, Matthew L., et al.
Publicado: (2013)

1079. When Does a Trans-Esophageal Echocardiogram (TEE) Change Management of Staphylococcus aureus Bacteremia (SAB)?
por: Lam, John, et al.
Publicado: (2018)

Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?
por: Skolnik, Kate, et al.
Publicado: (2017)

1813. A Population-Based Multi-Year Assessment of the Incidence of High Inoculum Cefazolin (CZ) Resistance Amongst Methicillin-Susceptible Staphylococcus aureus (MSSA) Causing Bloodstream Infections (BSIs) over time in Calgary, Canada
por: Du, Kristine, et al.
Publicado: (2022)

Metastatic Bladder Cancer Presenting with Persistent Hematuria in Young Man with Cystic Fibrosis
por: Patel, Premal, et al.
Publicado: (2013)

Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation
por: Thornton, Christina S, et al.
Publicado: (2022)

Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study
por: Thornton, Christina S, et al.
Publicado: (2015)

Microbiological Characterization of Actinotignum schaalii Strains Causing Invasive Infections during a Multiyear Period in a Large Canadian Health Care Region
por: Lieu, Anthony, et al.
Publicado: (2022)

Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?
por: Thornton, Christina, et al.
Publicado: (2021)

Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections
por: Sibley, Christopher D., et al.
Publicado: (2008)

Lymphocutaneous spread of Mycobacterium elephantis in an immunocompetent individual: A case report
por: Edwards, Brett D, et al.
Publicado: (2021)

Assessment of factors and interventions towards therapeutic adherence among persons with non-cystic fibrosis bronchiectasis
por: Thornton, Christina S., et al.
Publicado: (2022)

Timing of device reimplantation and reinfection rates following cardiac implantable electronic device infection: a systematic review and meta-analysis
por: Chew, Derek, et al.
Publicado: (2019)

Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis
por: Duong, Jessica, et al.
Publicado: (2015)

Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017
por: Edwards, Brett D., et al.
Publicado: (2020)

Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting
por: Edwards, Brett D., et al.
Publicado: (2021)

Draft Genome Sequence of Burkholderia dolosa PC543 Isolated from Cystic Fibrosis Airways
por: Workentine, Matthew L., et al.
Publicado: (2014)

Prosthetic joint and implant contamination caused by Ralstonia pickettii: a report of three cases
por: Edwards, Brett D., et al.
Publicado: (2017)

Cystic fibrosis physicians’ perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States
por: Ramos, Kathleen J., et al.
Publicado: (2017)

Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics
por: Strug, Lisa J., et al.
Publicado: (2016)

224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study
por: Niazi, Elaha, et al.
Publicado: (2021)

210. Evaluating the Costs of Escherichia coli Bloodstream Infections: A Population-Based Cohort Study
por: King, Teagan, et al.
Publicado: (2023)

Community-associated methicillin-resistant Staphylococcus aureus necrotizing pneumonia without evidence of antecedent viral upper respiratory infection
por: Toro, Cristina Moran, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qjn88lr90rf625mire7ag7r0jk